Cargando…
Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19
Mapping non-canonical cellular pathways affected by approved medications can accelerate drug repurposing efforts, which are crucial in situations with a global impact such as the COVID-19 pandemic. Fluoxetine and fluvoxamine are well-established and widely-used antidepressive agents that act as sero...
Autores principales: | Mahdi, Mohamed, Hermán, Levente, Réthelyi, János M., Bálint, Bálint László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998734/ https://www.ncbi.nlm.nih.gov/pubmed/35409171 http://dx.doi.org/10.3390/ijms23073812 |
Ejemplares similares
-
Tolerability and safety of fluvoxamine and other antidepressants
por: Westenberg, HGM, et al.
Publicado: (2006) -
Fluvoxamine for the treatment of COVID-19
por: Dodds, Michael G, et al.
Publicado: (2022) -
Fluvoxamine for the treatment of COVID-19
por: Boulware, David R, et al.
Publicado: (2022) -
Fluvoxamine for the treatment of COVID-19
por: Kim, Hyun, et al.
Publicado: (2022) -
Fluvoxamine for the treatment of COVID-19
por: Marzolini, Catia, et al.
Publicado: (2022)